ORTHOPEDICS AND TRAUMATOLOGY / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The aim was to examine data from the Global Burden of Disease Study (GBD) 2019 to determine the global burden of osteoarthritis (OA) from 1990 to 2019 that is attributable to high body mass index (BMI).

Material and methods:
Disability-adjusted life years (DALYs) and age-standardized DALY rates, and their corresponding estimated annual percentage changes (EAPCs), were used to compare estimated OA burdens between countries and regions. Moreover, a comparative risk assessment framework was used to estimate the risks attributable to high BMI in terms of DALYs.

Results:
From 1990 to 2019, the age-standardized DALY rate for OA attributable to high BMI increased significantly (EAPC = 1.45, 95% CI: 1.44–1.47). Moreover, from 1990 to 2019, the age-standardized DALY rate and number of DALYs for OA attributable to high BMI increased less in women than in men. From 1990 to 2019, the age-standardized DALY rate for OA attributable to high BMI increased the most in South Asia (EAPC = 3.94). From 1990 to 2019, among 204 countries worldwide, the age-standardized DALY rate for OA attributable to high BMI increased the most in Equatorial Guinea (EAPC = 7.42). Also, the burden was higher in high-sociodemographic index (SDI) regions than in low-SDI regions.

Conclusions:
The global burden of OA attributable to high BMI increased significantly from 1990 to 2019. In particular, this burden was higher in women than in men; primarily affected middle-aged and older adults; and was generally greater in high-SDI regions than in low-SDI regions.

REFERENCES (30)
1.
Wan J, Qian X, He Z, et al. Epidemiological trends of hand osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease study. Front Med (Lausanne) 2022; 9: 922321.
 
2.
Bosy-Westphal A, Muller MJ. Identification of skeletal muscle mass depletion across age and BMI groups in health and disease: there is need for a unified definition. Int J Obes (Lond) 2015; 39: 379-86.
 
3.
Xie J, Wang M, Long Z, et al. Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019. BMJ 2022; 379: e072385.
 
4.
Ackerman IN, Buchbinder R, March L. Global Burden of Disease Study 2019: an opportunity to understand the growing prevalence and impact of hip, knee, hand and other osteoarthritis in Australia. Intern Med J 2023; 53: 1875-82.
 
5.
Zhang MN, Li MT, Zhi XY, Zhu H, Zhang X, Xie J. Trends of a burden on atherosclerotic cardiovascular disease and its related risk factors in China, 1990 to 2019. Chinese J Epidemiol 2021; 42: 1797-803.
 
6.
Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol 2018; 30: 160-7.
 
7.
Silverwood V, Blagojevic-Bucknall M, Jinks C, Jordan JL, Protheroe J, Jordan KP. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2015; 23: 507-15.
 
8.
Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 2013; 21: 1145-53.
 
9.
Fatoye F, Gebrye T, Mbada C, Useh U. Economic evaluations of digital health interventions for the management of musculoskeletal disorders: systematic review and meta-analysis. J Med Internet Res 2023; 25: e41113.
 
10.
Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med 2011; 2: 205-12.
 
11.
Liu M, Jin F, Yao X, Zhu Z. Disease burden of osteoarthritis of the knee and hip due to a high body mass index in China and the USA: 1990-2019 findings from the global burden of disease study 2019. BMC Musculoskelet Disord 2022; 23: 63.
 
12.
Xue Y, Zhou J, Wang P, et al. Burden of tuberculosis and its association with socio-economic development status in 204 countries and territories, 1990-2019. Front Med (Lausanne) 2022; 9: 905245.
 
13.
Pelletier JP, Dorais M, Paiement P, Raynauld JP, Martel-Pelletier J. Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case-control study. Ther Adv Musculoskelet Dis 2022; 14: 1759720x221091359.
 
14.
Callhoff J, Albrecht K, Redeker I, et al. THU0429 disease burden of persons with osteoarthritis: results of a cross-sectional analysis from a survey linked to claims data in the Proclair project. Ann Rheum Dis 2019; 78 (Suppl 2): 502-3.
 
15.
Kusumaningtyas M, Tamtomo D, Murti B. Factors associated with the occurrence of osteoarthritis: a path analysis evidence from Surakarta, Central Java. J Epidemiol Public Health 2019; 4: 9-19.
 
16.
Li N, Deng Y, Zhou L, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol 2019; 12: 140.
 
17.
Sirman AE, Schmidt JE, Clark ME, Kittilson JD, Reed WL, Heidinger BJ. Compensatory growth is accompanied by changes in insulin-like growth factor 1 but not markers of cellular aging in a long-lived seabird. Am Nat 2023; 202: 78-91.
 
18.
Zhi X, Kuang ZH, Liu K, Li J. The global burden and temporal trend of cancer attributable to high body mass index: estimates from the Global Burden of Disease Study 2019. Front Nutr 2022; 9: 918330.
 
19.
Zhang X, Wang X, wang M, et al. The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990–2019: an analysis of the Global Burden of Disease Study. Front Public Health 2022; 10: 966093.
 
20.
Rogatkina T, Korolik O, Polyakov V, Kravtsov G, Polyakova Y. AB0875-HPR Non-pharmacological and pharmacological approaches to the management of patients with osteoarthritis and lipid metabolism disorders. Ann Rheum Dis 2021; 80 Suppl 1: 1461.
 
21.
Hoveidaei AH, Nakhostin-Ansari A, Chalian M, et al. Burden of knee osteoarthritis in the Middle East and North Africa (MENA): an epidemiological analysis from 1990 to 2019. Arch Orthop Trauma Surg 2023; 143: 6323-33.
 
22.
Shamekh A, Alizadeh M, Nejadghaderi SA, et al. The burden of osteoarthritis in the Middle East and North Africa region from 1990 to 2019. Front Med 2022; 9: 881391.
 
23.
Safiri S, Kolahi AA, Smith E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis 2020; 79: 819-28.
 
24.
Driban JB, Davis JE, Lu B, et al. Accelerated knee osteoarthritis is characterized by destabilizing meniscal tears and preradiographic structural disease burden. Arthritis Rheumatol 2019; 71: 1089-100.
 
25.
Fu M, Zhou H, Li Y, Jin H, Liu X. Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study. Arthritis Res Ther 2022; 24: 8.
 
26.
Posner SF. PCD recognizes outstanding student research: Patel et al on emergency medical services capacity for prehospital stroke care in North Carolina. Prev Chronic Dis 2013; 10: E150.
 
27.
Dean HD, Fenton KA. Addressing social determinants of health in the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted infections, and tuberculosis. Public Health Rep 2010; 125 (Suppl 4): 1-5.
 
28.
Singh A, Das S, Chopra A, et al. Burden of osteoarthritis in India and its states, 1990-2019: findings from the Global Burden of disease study 2019. Osteoarthritis Cartilage 2022; 30: 1070-8.
 
29.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204-22.
 
30.
Chen X, Tang H, Lin J, Zeng R. Temporal trends in the disease burden of osteoarthritis from 1990 to 2019, and projections until 2030. PLoS One 2023; 18: e0288561.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top